Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRISM: A Double Blind, Randomized, Vehicle Controlled Phase 2 Study to Assess the Safety and Efficacy of BPX-04 Minocycline Topical Gel in the Treatment of Inflammatory Lesions of Papulopustular Rosacea

NCT03667222 is registered in ClinicalTrials.gov with BioPharmX, Inc. as lead sponsor.

NCT NCT03667222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRISM: A Double Blind, Randomized, Vehicle Controlled Phase 2 Study to Assess the Safety and Efficacy of BPX-04 Minocycline Topical Gel in the Treatment of Inflammatory Lesions of Papulopustular Rosacea
Lead sponsor
BioPharmX, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
September 18, 2018
Completion date
August 17, 2019
Enrollment
207 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

papulopustular rosacea